Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study

Cells. 2021 May 23;10(6):1293. doi: 10.3390/cells10061293.

Abstract

The dysregulation of both the innate and adaptive responses to SARS-CoV-2 have an impact on the course of COVID-19, and play a role in the clinical outcome of the disease. Here, we performed a comprehensive analysis of peripheral blood lymphocyte subpopulations in 82 patients with COVID-19, including 31 patients with a critical course of the disease. In COVID-19 patients who required hospitalization we analyzed T cell subsets, including Treg cells, as well as TCRα/β and γ/δ, NK cells, and B cells, during the first two weeks after admission to hospital due to the SARS-CoV-2 infection, with marked reductions in leukocytes subpopulations, especially in critically ill COVID-19 patients. We showed decreased levels of Th, Ts cells, Treg cells (both naïve and induced), TCRα/β and γ/δ cells, as well as CD16+CD56+NK cells in ICU compared to non-ICU COVID-19 patients. We observed impaired function of T and NK cells in critically ill COVID-19 patients with extremely low levels of secreted cytokines. We found that the IL-2/INFγ ratio was the strongest indicator of a critical course of COVID-19, and was associated with fatal outcomes. Our findings showed markedly impaired innate and adaptive responses in critically ill COVID-19 patients, and suggest that the immunosuppressive state in the case of a critical course of SARS-CoV-2 infection might reflect subsequent clinical deterioration and predict a fatal outcome.

Keywords: COVID-19; IL-2; IL-2/INFγ ratio; INFγ; NK cells; T cells; TCR γ/δ cells; TCRα/β; TNFα; immunosuppression; lymphocyte subsets; regulatory T cells.

MeSH terms

  • Adaptive Immunity
  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / immunology*
  • COVID-19 / mortality
  • COVID-19 / virology
  • Clinical Deterioration
  • Critical Illness
  • Female
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Immune Tolerance*
  • Immunity, Innate
  • Leukocyte Count
  • Lymphocyte Subsets / immunology*
  • Male
  • Middle Aged
  • Poland / epidemiology
  • Prospective Studies
  • Risk Assessment / methods
  • SARS-CoV-2 / immunology*
  • Severity of Illness Index*